articleTop 1% cited

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

Breast Cancer Research and Treatment · 1993 · Vol. 24(3) · pp. 195–208

F. Jänicke✉Manfred Schmitt(Klinikum rechts der Isar)L. Pache(Klinikum rechts der Isar)Kurt Ulm(Institut für Angewandte Statistik)Nadia Harbeck(Klinikum rechts der Isar)Heinz Höfler(Ludwig-Maximilians-Universität München)H. Graeff(Klinikum rechts der Isar)

View via DOI Publisher page

Protease and Inhibitor Mechanisms Coagulation, Bradykinin, Polyphosphates, and Angioedema Cell Adhesion Molecules ResearchBreast cancerCathepsin DPlasminogen activator inhibitor-1OncologyPlasminogen activatorInternal medicineUrokinaseMedicineCancerMetastasis

MeSH terms

Antigens, NeoplasmBreast NeoplasmsCathepsin DFemaleHumansLymphatic MetastasisPrognosisProspective StudiesRecurrenceRisk FactorsUrokinase-Type Plasminogen ActivatorSurvival RateChemotherapy, AdjuvantPlasminogen Activator Inhibitor 1

Citations

359

FWCI

15.41

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation